Back

Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy and Migraine

2026-03-02 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

Topiramate (TPM) is approved for seizures and migraine prophylaxis and is used off-label for several neuropsychiatric conditions. The available dosage forms, including tablets and sprinkle capsules, are unsuitable for patients who may be unable to take medicine orally. The resulting potential treatment interruptions could have untoward consequences and underscores the importance of developing a parenteral formulation. In this study, we developed a population pharmacokinetic model of a novel, int...

Predicted journal destinations